| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An Anticancer Drug Unit for the whole provincial oncologic network of Piacenza: improving safety and savings
|
Mordenti, Patrizia
|
|
2014
|
32 |
2 |
p. 1-5
|
artikel
|
| 2 |
Association of RAGE polymorphisms and cancer risk: a meta-analysis of 27 studies
|
Xia, Wenjie
|
|
2015
|
32 |
2 |
p. 1-9
|
artikel
|
| 3 |
A systematic review and meta-analysis of the association between OGG1 Ser326Cys polymorphism and cancers
|
Zhou, Ping-Ting
|
|
2015
|
32 |
2 |
p. 1-16
|
artikel
|
| 4 |
CCR7 pathway induces epithelial–mesenchymal transition through up-regulation of Snail signaling in gastric cancer
|
Zhang, Jianping
|
|
2014
|
32 |
2 |
p. 1-9
|
artikel
|
| 5 |
Clinical efficacy of preoperative chemotherapy with or without ifosfamide in patients with osteosarcoma of the extremity: meta-analysis of randomized controlled trials
|
Su, Wenmei
|
|
2015
|
32 |
2 |
p. 1-7
|
artikel
|
| 6 |
Clinical outcomes of Chinese patients with metastatic colorectal cancer receiving first-line bevacizumab-containing treatment
|
Bai, Long
|
|
2015
|
32 |
2 |
p. 1-10
|
artikel
|
| 7 |
Clinicopathological features of thirty patients with primary breast lymphoma and review of the literature
|
Shao, Y. B.
|
|
2014
|
32 |
2 |
p. 1-6
|
artikel
|
| 8 |
Dose-dense biweekly docetaxel combined with 5-fluorouracil as first-line treatment in advanced gastric cancer: a phase II trial
|
Xiao, Jian
|
|
2015
|
32 |
2 |
p. 1-7
|
artikel
|
| 9 |
Efficacy and safety of chemotherapy or tyrosine kinase inhibitors combined with bevacizumab versus chemotherapy or tyrosine kinase inhibitors alone in the treatment of non-small cell lung cancer: a systematic review and meta-analysis
|
Sun, Li
|
|
2015
|
32 |
2 |
p. 1-11
|
artikel
|
| 10 |
Exosomal Hsp70 mediates immunosuppressive activity of the myeloid-derived suppressor cells via phosphorylation of Stat3
|
Diao, Jianjun
|
|
2015
|
32 |
2 |
p. 1-10
|
artikel
|
| 11 |
Human mammary microenvironment better regulates the biology of human breast cancer in humanized mouse model
|
Zheng, Ming-Jie
|
|
2014
|
32 |
2 |
p. 1-11
|
artikel
|
| 12 |
Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10/STAT3/bcl-2 signaling pathway
|
Yang, Cuixia
|
|
2014
|
32 |
2 |
p. 1-8
|
artikel
|
| 13 |
Intraperitoneal administration of cisplatin plus bevacizumab for the management of malignant ascites in ovarian epithelial cancer: results of a phase III clinical trial
|
Zhao, Hui
|
|
2015
|
32 |
2 |
p. 1-7
|
artikel
|
| 14 |
Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathway
|
Li, Pei-Pei
|
|
2015
|
32 |
2 |
p. 1-9
|
artikel
|
| 15 |
Microwave ablation plus chemotherapy improved progression-free survival of advanced non-small cell lung cancer compared to chemotherapy alone
|
Wei, Zhigang
|
|
2014
|
32 |
2 |
p. 1-8
|
artikel
|
| 16 |
MLF1 interacting protein: a potential gene therapy target for human prostate cancer?
|
Zhang, Lei
|
|
2014
|
32 |
2 |
p. 1-7
|
artikel
|
| 17 |
Molecular response to imatinib in chronic myeloid leukaemia with a variant e13a3 BCR–ABL1 fusion
|
McCarron, Sarah L.
|
|
2015
|
32 |
2 |
p. 1-4
|
artikel
|
| 18 |
N-cadherin participated in invasion and metastasis of human esophageal squamous cell carcinoma via taking part in the formation of vasculogenic mimicry
|
Wang, Feng
|
|
2015
|
32 |
2 |
p. 1-8
|
artikel
|
| 19 |
Outcomes of peripheral blood stem cell transplantation patients from HLA-mismatched unrelated donor with antithymocyte globulin (ATG)-Thymoglobulin versus ATG-Fresenius: a single-center study
|
Huang, Wenrong
|
|
2015
|
32 |
2 |
p. 1-8
|
artikel
|
| 20 |
Patients with distal intestinal gastric cancer have superior outcome with addition of taxanes to combination chemotherapy, while proximal intestinal and diffuse gastric cancers do not: does biology and location predict chemotherapy benefit?
|
Sedef, Ali Murat
|
|
2015
|
32 |
2 |
p. 1-5
|
artikel
|
| 21 |
Peperotetraphin inhibits the proliferation of human prostate cancer cells via induction of cell cycle arrest and apoptosis
|
Li, Yunzhi
|
|
2015
|
32 |
2 |
p. 1-6
|
artikel
|
| 22 |
Peroxiredoxin 1 promotes tumorigenesis through regulating the activity of mTOR/p70S6K pathway in esophageal squamous cell carcinoma
|
Gong, Fanghua
|
|
2015
|
32 |
2 |
p. 1-9
|
artikel
|
| 23 |
Prognostic factors for survival with bevacizumab-based therapy in colorectal cancer patients: a systematic review and pooled analysis of 11,585 patients
|
Petrelli, Fausto
|
|
2014
|
32 |
2 |
p. 1-10
|
artikel
|
| 24 |
Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome
|
Leng, Ruobing
|
|
2015
|
32 |
2 |
p. 1-12
|
artikel
|
| 25 |
Rapid response of brain metastases to alectinib in a patient with non-small-cell lung cancer resistant to crizotinib
|
Ajimizu, Hitomi
|
|
2015
|
32 |
2 |
p. 1-2
|
artikel
|
| 26 |
RBMS3 is a tumor suppressor gene that acts as a favorable prognostic marker in lung squamous cell carcinoma
|
Liang, Ya-nan
|
|
2015
|
32 |
2 |
p. 1-9
|
artikel
|
| 27 |
Retraction Note to: The hypoxia-inducible factor-1 regulates the microRNA185 expression through binding to hypoxia response elements sequence 2
|
Song, Zhenguo
|
|
2014
|
32 |
2 |
p. 1
|
artikel
|
| 28 |
Sentinel lymph node biopsy in breast cancer: the role of micrometastasis
|
Pérez-Callejo, David
|
|
2015
|
32 |
2 |
p. 1-5
|
artikel
|
| 29 |
SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-κB/ERK/Akt signaling pathway
|
Li, Jin
|
|
2014
|
32 |
2 |
p. 1-9
|
artikel
|
| 30 |
SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-κB/ERK/Akt signaling pathway
|
Li, Jin
|
|
|
32 |
2 |
|
artikel
|
| 31 |
Single-agent bevacizumab is an effective treatment in recurrent glioblastoma
|
Hacibekiroglu, Ilhan
|
|
2014
|
32 |
2 |
p. 1-6
|
artikel
|
| 32 |
Slug signaling is up-regulated by CCL21/CXCR7 to induce EMT in human chondrosarcoma
|
Li, Guosong
|
|
2015
|
32 |
2 |
p. 1-7
|
artikel
|
| 33 |
Sorafenib reverses resistance of gastric cancer to treatment by cisplatin through down-regulating MDR1 expression
|
Huang, Yi-sheng
|
|
2015
|
32 |
2 |
p. 1-6
|
artikel
|
| 34 |
SOX5 promotes epithelial–mesenchymal transition and cell invasion via regulation of Twist1 in hepatocellular carcinoma
|
Wang, Dong
|
|
2014
|
32 |
2 |
p. 1-8
|
artikel
|
| 35 |
Survivorship in untreated breast cancer patients
|
Galmarini, Carlos M.
|
|
2015
|
32 |
2 |
p. 1-7
|
artikel
|
| 36 |
Therapeutic efficacy evaluation of postoperative adjuvant radiotherapy in mid-thoracic esophageal carcinoma patients underwent Ivor Lewis esophagectomy with two-field lymphadenectomy
|
Yu, Yang
|
|
2014
|
32 |
2 |
p. 1-6
|
artikel
|
| 37 |
Third-line chemotherapy with carboplatin, gemcitabine and liposomised doxorubicin for malignant pleural mesothelioma
|
Lima, Vinicius Araújo B. de
|
|
2014
|
32 |
2 |
p. 1-7
|
artikel
|
| 38 |
Treatment on advanced NSCLC: Platinum-based chemotherapy plus erlotinib or platinum-based chemotherapy alone? A systematic review and meta-analysis of randomised controlled trials
|
Zhou, Jian-Guo
|
|
2015
|
32 |
2 |
p. 1-10
|
artikel
|
| 39 |
Trial of LVDP regimen (l-asparaginase, etoposide, dexamethasone, and cisplatin, followed by radiotherapy) as first-line treatment for newly diagnosed, stage III/IV extranodal natural killer/T cell lymphoma
|
Wang, Y. Q.
|
|
2014
|
32 |
2 |
p. 1-9
|
artikel
|
Tijdschrift beschrijving